| Product Code: ETC12463402 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Imatinib Drug Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Imatinib Drug Market - Industry Life Cycle |
3.4 South Korea Imatinib Drug Market - Porter's Five Forces |
3.5 South Korea Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 South Korea Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 South Korea Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 South Korea Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 South Korea Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 South Korea Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in South Korea |
4.2.2 Growing awareness about the effectiveness of imatinib in treating CML |
4.2.3 Advancements in healthcare infrastructure and access to treatment in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and pricing in South Korea |
4.3.2 Competition from generic imatinib drugs impacting market share |
4.3.3 Potential side effects and adverse reactions associated with imatinib treatment |
5 South Korea Imatinib Drug Market Trends |
6 South Korea Imatinib Drug Market, By Types |
6.1 South Korea Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 South Korea Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 South Korea Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 South Korea Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 South Korea Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 South Korea Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 South Korea Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 South Korea Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 South Korea Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 South Korea Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 South Korea Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 South Korea Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 South Korea Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 South Korea Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Korea Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 South Korea Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 South Korea Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 South Korea Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 South Korea Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 South Korea Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 South Korea Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 South Korea Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 South Korea Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 South Korea Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 South Korea Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 South Korea Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 South Korea Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 South Korea Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 South Korea Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 South Korea Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 South Korea Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 South Korea Imatinib Drug Market Import-Export Trade Statistics |
7.1 South Korea Imatinib Drug Market Export to Major Countries |
7.2 South Korea Imatinib Drug Market Imports from Major Countries |
8 South Korea Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Rate of new CML diagnoses in South Korea |
8.3 Number of healthcare facilities offering imatinib treatment |
8.4 Research and development investment in improving imatinib efficacy |
8.5 Patient satisfaction and quality of life outcomes post imatinib treatment |
9 South Korea Imatinib Drug Market - Opportunity Assessment |
9.1 South Korea Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 South Korea Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 South Korea Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 South Korea Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 South Korea Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 South Korea Imatinib Drug Market - Competitive Landscape |
10.1 South Korea Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 South Korea Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here